Cargando…
Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland
PURPOSE: The purpose was to assess the number and intervals of dexamethasone intravitreal implant (DEX) reinjections in a real-world setting for the treatment of diabetic macular edema (DME) and to determine the relationship with effectiveness and safety. PATIENTS AND METHODS: Data were abstracted f...
Autores principales: | Augustin, Albert J, Becker, Matthias D, Hatz, Katja, Kaymak, Hakan, Shirlaw, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489531/ https://www.ncbi.nlm.nih.gov/pubmed/34616140 http://dx.doi.org/10.2147/OPTH.S315548 |
Ejemplares similares
-
Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2006) -
The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen
por: Takamura, Yoshihiro, et al.
Publicado: (2021) -
Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema
por: Akıncıoğlu, Dorukcan, et al.
Publicado: (2017) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015) -
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
por: Koc, Hakan, et al.
Publicado: (2023)